about
Interventions for vitiligoInterventions for vitiligoVariant of TYR and autoimmunity susceptibility loci in generalized vitiligoGenetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and LociCurrent aspects of vitiligo geneticsVitiligo--part 1Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8Vitiligo in adults and children.Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.Treatment of segmental vitiligo with normal-hair follicle autograft.The polymorphism of catalase T/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis.Vitiligo road map.Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership.Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onsetVitiligo in adults and children: surgical interventions.A functional single-nucleotide polymorphism in the ERCC1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population.The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients.Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgarisPrevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo.Fabrication of anti-vitiligo ointment containing Psoralea corylifolia: in vitro and in vivo characterization.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.Multiple autoimmune syndromes associated with psoriasis: a rare clinical presentation.Vitiligo, reactive oxygen species and T-cells.Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo.Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.Autoimmune comorbid diseases associated with lichen planus: a nationwide case-control study.3-Methyladenine DNA glycosylase is important for cellular resistance to psoralen interstrand cross-links.An extraordinary colocalization of alopecia areata and vitiligo.Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease.Double-stranded RNA induces melanocyte death via activation of Toll-like receptor 3.Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms.A proliferation-inducing ligand in atopic dermatitis and vitiligo.Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab.Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo.Macrophage migration inhibitory factor as an incriminating agent in vitiligo.
P2860
Q24187979-61BA9B12-9DD1-40BD-A734-AC3869DB20CDQ24240527-713244BA-8C21-4D88-894F-C2F81D9B4ADBQ24629443-596B764A-9F29-43B4-8CB2-5EA5FAE3C7C5Q26766384-6DCB19D2-ED35-4DEE-97D9-B345D9D532E2Q27003993-28B7BD0E-C113-48EB-9B7B-073B3EA04605Q27028001-E12BEE4A-248E-473B-84E6-3D49643D7324Q28943256-C2956635-106C-48D8-A226-A6E38C6BBCEBQ31004500-0E86900F-E6B7-43E8-9455-3B56D09226A8Q33471405-F70CF7CB-1509-4A1E-83BD-C424468BAEBBQ33571655-4741711C-F36F-4F6A-8C38-DF1878B6851FQ33739828-D963ABB9-7978-46E6-A371-6BD8BBE24AA3Q34511375-0000FA53-FF82-4F5C-ABF8-9CF5FC2B0B27Q34886046-9A745C6F-67C2-4CEE-810E-BF260C2EBB5FQ35212036-10B32786-0921-4869-8B2F-03C0E5BC7EB7Q35584658-D3AC04B2-CAFC-4EC7-B563-8F1714660362Q35627933-6449AED5-63F6-4551-B5EA-EE9A07D44BB1Q36013154-1F9009D9-85C8-4E6D-A9A0-D3A010A8B35DQ37371455-D8E38216-3286-4C78-B9A3-9543D8FA4A64Q37413965-75F23ECD-E0BB-449E-9D1D-5253B1FE7E02Q37446554-7CA44C50-047B-4CB5-BB37-D10A52B55E35Q37611016-C9E5816E-9F1F-4A42-B897-34307D090859Q37686499-B9B2384A-B5C1-442B-8669-4D53F9A767EAQ37801388-EFBAB0FD-ED27-4588-803A-DC06D3F81B46Q38025487-6EA8FBDC-C999-4B83-89F5-9E0469C0E34EQ38943432-777A1297-484C-4FCA-A64C-262F172AD5EFQ38956815-D0E50F6A-B98C-48A7-838D-5656B15C5331Q41644005-56DC961F-4A80-4D63-AD54-3F806CF91705Q42709830-9B538214-14BA-40B0-B27E-2CD724410C34Q42731427-031F4FE7-90F4-4991-82D5-5CBBBC68E3D5Q43252679-30C620E2-EA0B-41CD-8F69-70A0B5319F80Q43778364-F5A821C0-A0C5-444B-BACD-B0325F790D6DQ43840213-E9A4B99B-6B33-4244-87B0-1BA74CA2AF40Q46503881-3845DE43-1446-4F43-8A46-D6D1BBDCD772Q47860341-B1A641C4-FE26-463C-A502-B4766D7219FAQ51032468-7B60731D-D4FB-4A73-9470-ECE5EE242D30Q53686506-3A89228B-A3CC-47D1-8D72-BFB7A8201E27
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Autoimmunity as an aetiological factor in vitiligo.
@en
type
label
Autoimmunity as an aetiological factor in vitiligo.
@en
prefLabel
Autoimmunity as an aetiological factor in vitiligo.
@en
P2093
P2860
P1476
Autoimmunity as an aetiological factor in vitiligo.
@en
P2093
P2860
P304
P356
10.1111/J.1468-3083.2007.02228.X
P577
2007-08-01T00:00:00Z